TradesZ
Top 10 stocks to add now
← All stocks
TECH

TECH — BIO-TECHNE Corp

CIK 842023 · SEC EDGAR fundamentals

Latest 10-K filed August 22, 2025 · period ending June 30, 2023

Smart money in TECH

Famous investors holding it (13F) + members of Congress who disclosed trading it (STOCK Act). Public SEC data.

How we track smart money →

13F shows long U.S. positions per the filing date; congressional trades are member-disclosed under the STOCK Act. Informational, not advice.

Headline figures

Revenue
$1.14B

Top-line sales for the most-recent fiscal year

FY2025 · 10-K

Net income
$285.3M
+4.9% vs prior year

Profit after all expenses, taxes, interest

FY2025 · 10-K

EPS (diluted)
$1.76
+6.0% vs prior year

Net income per diluted share outstanding

FY2025 · 10-K

Op. cashflow
$254.4M
-21.8% vs prior year

Cash actually generated by the business

FY2025 · 10-K

Balance sheet

Total assets
$2.70B

Everything the company owns

FY2025 · 10-K

Total liabilities

Everything the company owes

Stockholders equity
$1.97B

Assets minus liabilities (book value)

FY2024 · 10-K

Long-term debt

Debt due more than 12 months out

Read the source

All figures on this page were filed by BIO-TECHNE Corp with the SEC and pulled directly from EDGAR's XBRL CompanyFacts API. Click below to view the latest annual report (10-K) in full.

Open latest 10-K on SEC EDGAR →

Data sources & methodology

All figures derive from official, public-domain government filings. Read our methodology for how we collect, process and score this data. See the methodology →

TZ Researched & published by TradesZ Research

Not investment advice. Figures sourced from the SEC's XBRL CompanyFacts API — public-domain federal records. Companies occasionally restate prior-year numbers; we show the latest filed value per fiscal year.